IRIS
BIANCONI, MARISTELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.804
EU - Europa 907
AS - Asia 199
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 1
Totale 2.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.804
IT - Italia 237
UA - Ucraina 192
SE - Svezia 120
IE - Irlanda 105
TR - Turchia 99
DE - Germania 86
DK - Danimarca 75
FI - Finlandia 53
KR - Corea 41
SG - Singapore 35
GB - Regno Unito 23
CN - Cina 14
IN - India 9
BE - Belgio 8
FR - Francia 5
EU - Europa 4
DZ - Algeria 3
NL - Olanda 2
BR - Brasile 1
CI - Costa d'Avorio 1
RS - Serbia 1
VN - Vietnam 1
Totale 2.919
Salva come PNG Salva come JPEG
Città #
Chandler 236
Fairfield 217
Jacksonville 206
Wilmington 136
Ashburn 108
Dublin 105
Centro 96
Seattle 95
Woodbridge 83
Houston 73
Ann Arbor 69
New York 62
Cambridge 59
Des Moines 51
Lawrence 43
Princeton 43
San Mateo 43
Turin 43
Boardman 36
San Diego 17
Helsinki 15
Beijing 14
Pune 9
Brussels 8
Izmir 8
London 7
Cagliari 6
Los Angeles 6
Norwalk 6
Kilburn 5
Washington 5
New Bedfont 3
Amantea 2
Amsterdam 2
Chicago 2
Como 2
Marche 2
Milan 2
Modena 2
Montesilvano 2
Porto 2
Prescot 2
Rome 2
Scafati 2
Venice 2
Abidjan 1
Acton 1
Ascoli Piceno 1
Belgrade 1
Berlin 1
Brasília 1
Chiswick 1
Civitanova Marche 1
Cupra Marittima 1
Dong Ket 1
Frankfurt (Oder) 1
Hanover 1
Hounslow 1
Islington 1
Matelica 1
Pesaro 1
San Francisco 1
San Giuliano 1
Seoul 1
Simi Valley 1
Stamford 1
Torre Del Greco 1
Totale 1.961
Salva come PNG Salva come JPEG
Nome #
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 124
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 112
Immunotherapy in genitourinary cancers: Where are we going? 112
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 106
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 98
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 94
Adjuvant treatment after surgical resection 82
Il profilo angiogenico nel carcinoma renale metastatico: implicazioni prognostiche e terapeutiche 80
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 79
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 79
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 79
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 79
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 78
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 77
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 76
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 75
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 73
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 73
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 72
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 72
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 72
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 71
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 69
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 69
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 63
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 62
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 62
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 62
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 61
Panitumumab for the treatment of metastatic colorectal cancer: A review 61
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 57
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 55
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 53
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 52
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. 52
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 52
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 52
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 52
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 51
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 51
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma 46
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 38
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 32
Totale 3.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 0 8
2019/2020244 0 0 36 3 42 0 41 7 41 5 12 57
2020/2021769 47 71 82 4 126 74 70 48 54 100 64 29
2021/2022370 35 92 4 5 2 19 21 22 18 53 29 70
2022/2023727 53 98 59 48 47 114 1 38 166 3 83 17
2023/2024308 61 2 29 45 54 93 6 11 1 6 0 0
Totale 3.015